Navigation Links
Access Pharmaceuticals Announces Poster Presentations on ProLindac,at the American Association for Cancer Research 2007 Annual Meeting

DALLAS, April 16, 2007 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. announced today that results of studies of the mechanism of ProLindac's anticancer activity will be presented today at the American Association for Cancer Research (AACR) 2007 annual meeting in Los Angeles at the Los Angeles Convention Center. The two poster presentations describe preclinical studies performed by Access collaborators at two prominent institutes in France.

"We are delighted to have two ProLindac poster presentations at one of the most prestigious scientific conferences in cancer," stated David P. Nowotnik, Access' Senior Vice President, Research and Development. "The presentations reaffirm ProLindac's potential to become a leading cancer treatment. The posters focus on how ProLindac can be delivered in much higher doses than current therapies and shows its potential for superior efficacy, given alone as well as in combination with other anticancer compounds. Access has successfully completed a Phase 1 clinical study indicating at least five times more platinum could be administered to patients with ProLindac than oxaliplatin before the onset of toxicity. We are currently studying ProLindac in a Phase 2 monotherapy trial, treating patients with relapsed ovarian cancer."

The first poster is entitled "Antiproliferative effects of ProLindac, a novel DACH-platinum linked polymer-compound, compared to oxaliplatin and cisplatin in a panel of human cancer cell lines." This poster describes studies which examine ProLindac's cytotoxic effects either as single agent or in combination with other cytotoxics, and molecular mechanisms of action of ProLindac in comparison to oxaliplatin and cisplatin in a panel of human cancer cell lines. Results of the study indicated ProLindac and oxaliplatin showed similar cytotoxicity profiles when used in combination with either Gemcitabine, Docetaxel, 5-FU or SN38 (a camptothecin a
'"/>




Page: 1 2 3 4

Related medicine technology :

1. PromegaExpress Expands Easy Access to Products with New Cabinet
2. Access and Somanta Announce Data to be Presented on Angiolix at ASCO Oncology Conference
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
(Date:7/28/2014)... 2014  Surgical Theater, LLC announced today the ... Advisory Board. New members include Ori J. ... Development and New Technologies for Given Imaging Ltd., ... Vice President and General Manager of Philips Healthcare,s ... simulation technology to brain surgery and has developed ...
(Date:7/28/2014)... July 28, 2014  Air Products (NYSE: ... medical oxygen is vital to any healthcare facility. This ... not only improve the efficiency of its oxygen supply ... highlight these systems—including systems for emergency oxygen supply ... August 4-5 at the 51 st ASHE ...
(Date:7/28/2014)... -- UBM Medica US announces that Diagnostic Imaging ... professionals, explored the complex situation regarding measuring the ... The shift from fee-for-service has left radiology at a ... determined in the new payment model . ... who recognized the complexity of the radiologist,s value: ...
Breaking Medicine Technology:Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 2Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 3Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 4Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 5Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 3Diagnostic Imaging Delves into Measuring the Radiologist's Value 2
... Valeant Pharmaceuticals International, Inc. (the "Company" or "Valeant") ... Intention to make a normal course issuer bid with ... TSX has accepted the Notice of Intention. Under the ... for cancellation, commencing August 25, 2011, 1,000,000 of its ...
... a leading provider of healthcare IT and medical billing solutions, ... 2011 Inc. 5000 list, a compendium of the most entrepreneurial ... the second year in a row that ITelagen qualified for ... position #2093, with an extraordinary four-year growth rate of 120.22%. ...
Cached Medicine Technology:Valeant Pharmaceuticals Files a Notice of Intention to Make a Normal Course Issuer Bid 2Valeant Pharmaceuticals Files a Notice of Intention to Make a Normal Course Issuer Bid 3ITelagen Named to Prestigious 2011 Inc. 5000 List of Fastest-Growing Companies 2
(Date:7/28/2014)... version of a surgical procedure to treat severe chronic ... 90 percent of the time in patients treated at ... Division of Plastic and Reconstructive Surgery report that more ... procedure all of whom had headaches associated with ... a year later. The team,s paper has received ...
(Date:7/28/2014)... 2014 Thousands of DePuy Pinnacle hip ... individuals who were allegedly injured by a metal-on-metal version ... forward in U.S. District Court, Northern District of Texas, ... on July 18, 2014, U.S. District Judge Ed Kinkeade ... Plaintiffs’ Steering Committee that sought the deposition of a ...
(Date:7/28/2014)... Glutamine is the most abundant single ... be conditionally essential during times when the body undergoes ... & Immune System Support. , Having a heavy work ... supplementing with additional glutamine may be advantageous. Glutamine supplementation ... body, digestion and immune system function. Stress on the ...
(Date:7/28/2014)... FL (PRWEB) July 28, 2014 Ticket ... vs. Colombia tickets in Miami, FL at the Sun ... in South American football between Argentina and Brazil has is ... getting stronger worldwide, more rivalries are forming on a consistent ... Colombia reached a new height in the recent 2014 World ...
(Date:7/28/2014)... chronic medical conditions people have at retirement age, the ... claims. Since nearly four in five older ... Bloomberg School of Public Health in Baltimore said the ... are slowing in the United States. "Living with ... heart failure is now the norm and not the ...
Breaking Medicine News(10 mins):Health News:Non-endoscopic migraine surgery provides significant symptom relief 2Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 4Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 2Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 3Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Showdown 2Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Showdown 3Health News:Chronic Medical Conditions Can Shorten Seniors' Lives: Study 2
... Presentations by Tony Yaksh, Ph.D.; Jerome Goldstein, M.D.; and ... ... A Webinar hosted by,TorreyPines Therapeutics, Inc. (Nasdaq: TPTX ) at ... discuss the opportunity of treating,chronic pain, migraine and muscle spasticity through ...
... therapies found medications cut withdrawal, urge to drink , , ... regimen of prescribed medications is the most effective way ... in those being treated for alcohol dependence, according to ... medications (naltrexone and acamprosate) used in combination with two ...
... (June 20, 2008) Turmeric, an Asian spice found ... in reducing inflammation, healing wounds and relieving pain, but ... role in many diseases and is believed to be ... diabetes, Drew Tortoriello, M.D., an endocrinologist and research scientist ...
... fundraising challenge, MILLERSVILLE, Md., June 20 ... vacation accommodations,found a unique way to raise awareness ... that causes patches of hair loss on parts ... Vacation Services Department Assistant Manager Steve Ogden,promised to ...
... in Newark, NEWARK, N.J., June 20 People from ... cancer survivors and,remember those who lost their battle with the ... will gather on June 28th at Newark Bears Stadium and,walk ... event called Relay,For Life. The event is held overnight to ...
... CITY -- Women who reported having both a sexually ... before or during early pregnancy were four times more ... in which infants are born with their intestines and ... researchers report in the online British Medical Journal ...
Cached Medicine News:Health News:Webinar on June 25 to Focus on Opportunity for Treating Chronic Pain, Migraine and Muscle Spasticity Through Inhibition of Neurotransmitter Glutamate 2Health News:Webinar on June 25 to Focus on Opportunity for Treating Chronic Pain, Migraine and Muscle Spasticity Through Inhibition of Neurotransmitter Glutamate 3Health News:Webinar on June 25 to Focus on Opportunity for Treating Chronic Pain, Migraine and Muscle Spasticity Through Inhibition of Neurotransmitter Glutamate 4Health News:Prescribed Meds Still Best Treatment for Alcoholism 2Health News:Common cooking spice shows promise in combating diabetes and obesity 2Health News:TAN Employees Shave the Way for the Fight Against Alopecia 2Health News:Sexually transmitted disease, urinary tract infections may be bad combination for birth defect 2Health News:Sexually transmitted disease, urinary tract infections may be bad combination for birth defect 3
BD Beaver Cataract blade, 30.0 mm long x 2.2 mm wide, designed for ICCE and ECCE procedures, designed for ICCE and ECCE, sterile....
BD Beaver implant blade, 5.1 mm, angled 45, bevel up. matte finish. Designed for widening the incision for lens implantation. Beaver implant blades put precision and control in your hands, sterile....
BD Beaver Sickle Edge blade, straight, 5.0 mm W x 84 mm long. Specially designed for superior visibility and easy access into the ear canal, sterile....
BD Beaver Meniscus blade, 7 mm flat (4/bx, 1 bx/ca), specially designed maximum leverage and visibility, cutting edge: 7 mm, sterile....
Medicine Products: